Hopeful Advancements for Chronic Myeloid Leukemia (CML)

Join us as we speak to Dr. Richard Larson and Dr. Anand Patel from University of Chicago Medicine about chronic myeloid leukemia (CML). In this episode, they discuss the latest advances in treatment for CML and what is on the horizon.

With decades of progress with targeted treatments, CML patients are now given more hope of achieving deep remission and potentially discontinuing medication. A cure for an incurable disease may now be in sight.

CLICK HERE to participate in our episode survey.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode is provided by University of Chicago Comprehensive Cancer Center.


  1. Some really clear explanations of treatment and diagnosis. Thanks a lot.

    Rick, Salt Lake City. Diagnosed November 2019.

  2. At about minute 33 Dr Patel says you can live as long and “as well” as someone without CML. So far that has not been the case for me. Definitely feeling the chronic fatigue and gut issues two years in. But dasantib has make the BRC undetectable. Hopeful to be able to go off it.

  3. My niece was diagnosed at age 16 with CML would like to know what studies have shown for survival rate for teens with CML and or remission rates for teens. She has been on treatment with Sprycel 100 milligrams

    1. Hi Patty,

      We encourage you to contact our Information Specialists. They will be able to give more information on survival rates specific to your niece’s diagnosis. You can contact them at 1-800-955-4572 or go to LLS.org/ContactUs.

      Thank you for listening to the Bloodline! We hope this podcast helped you and your family.

Leave a Comment

Your email address will not be published. Required fields are marked *